Answers are grounded in this paper and cite their sources.
Case report demonstrates robotic resection of a rare chest wall tumor, indicating the need for thorough molecular testing.
Extra-enteric malignant gastrointestinal neuroectodermal tumors (E-MGNET) are rare and aggressive sarcomas driven by the Erwing's sarcoma gene and activating transcription factor, EWSR1-ATF1 fusion oncogene, and surgical resection is the gold standard. There is only one previously reported study of a tumor originating from the chest wall. Our study reports a rare second case of a chest wall E-MGNET in a young 34-year-old female patient. We discuss the importance of complete molecular testing to identify the correct diagnoses and describe the robotic laparoscopic-assisted surgical technique used to remove the chest wall tumor en bloc with negative margins using a Gigli saw.
No takes yet. Share an insight, caveat, or question.
Yates et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: